NO955347L - Hormonelt middel for terapi av akne samt anvendelse derav - Google Patents

Hormonelt middel for terapi av akne samt anvendelse derav

Info

Publication number: NO955347L
Authority: NO; Norway
Prior art keywords: hormonal; hormone; daily units; component; hormone component
Prior art date: 1993-07-01

Application number

NO955347A

Other languages

English (en)

Other versions

NO955347D0 (no

NO308586B1 (no

Inventor

Marika Ehrich

Herbert Kuhl

Original Assignee

Marika Ehrich

Herbert Kuhl

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-07-01

Filing date

1995-12-29

Publication date

1995-12-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6491735&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO955347(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-12-29 Application filed by Marika Ehrich, Herbert Kuhl filed Critical Marika Ehrich

1995-12-29 Publication of NO955347D0 publication Critical patent/NO955347D0/no

1995-12-29 Publication of NO955347L publication Critical patent/NO955347L/no

2000-10-02 Publication of NO308586B1 publication Critical patent/NO308586B1/no

Links

229940125697 hormonal agent Drugs 0.000 title abstract 3
208000002874 Acne Vulgaris Diseases 0.000 title abstract 2
206010000496 acne Diseases 0.000 title abstract 2
238000002560 therapeutic procedure Methods 0.000 title 1
239000005556 hormone Substances 0.000 abstract 5
229940088597 hormone Drugs 0.000 abstract 5
230000003054 hormonal effect Effects 0.000 abstract 4
239000000262 estrogen Substances 0.000 abstract 2
238000004806 packaging method and process Methods 0.000 abstract 2
101600111816 Homo sapiens Sex hormone-binding globulin (isoform 1) Proteins 0.000 abstract 1
102300044179 Sex hormone-binding globulin isoform 1 Human genes 0.000 abstract 1
239000013543 active substance Substances 0.000 abstract 1
230000002280 anti-androgenic effect Effects 0.000 abstract 1
239000000051 antiandrogen Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Dermatology (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Materials For Medical Uses (AREA)
Physical Or Chemical Processes And Apparatus (AREA)

NO955347A 1993-07-01 1995-12-29 Anvendelse av et hormonelt middel ved fremstilling av et preparat for terapi av akne NO308586B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE4321957A DE4321957C2 (de)	1993-07-01	1993-07-01	Verwendung eines hormonalen Mittels zur Therapie der Akne
PCT/DE1994/000629 WO1995001180A1 (de)	1993-07-01	1994-06-03	Hormonales mittel zur therapie der akne und dessen verwendung

Publications (3)

Publication Number	Publication Date
NO955347D0 NO955347D0 (no)	1995-12-29
NO955347L true NO955347L (no)	1995-12-29
NO308586B1 NO308586B1 (no)	2000-10-02

Family

ID=6491735

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO955347A NO308586B1 (no)	1993-07-01	1995-12-29	Anvendelse av et hormonelt middel ved fremstilling av et preparat for terapi av akne

Country Status (14)

Country	Link
EP (1)	EP0710111B1 (no)
JP (1)	JPH09500112A (no)
AT (1)	ATE205716T1 (no)
AU (1)	AU695894B2 (no)
BR (1)	BR9407340A (no)
CA (1)	CA2166121A1 (no)
DE (2)	DE4321957C2 (no)
DK (1)	DK0710111T3 (no)
ES (1)	ES2164103T3 (no)
HU (1)	HUT73234A (no)
NO (1)	NO308586B1 (no)
PT (1)	PT710111E (no)
UA (1)	UA43337C2 (no)
WO (1)	WO1995001180A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19534209A1 (de) *	1995-09-15	1997-03-20	Jenapharm Gmbh	Hormonales Mittel zur Behandlung der Haut
AU1690399A (en) *	1997-12-26	1999-07-19	Mochida Pharmaceutical Co., Ltd.	Neovascularization inhibitor containing dienogest as the active ingredient
DE102004026679A1 (de)	2004-05-28	2005-12-15	Grünenthal GmbH	Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
DE102004026671A1 (de)	2004-05-28	2005-12-15	Grünenthal GmbH	Darreichungsform zur hormonalen Kontrazeption
DE102004026670A1 (de)	2004-05-28	2005-12-15	Grünenthal GmbH	Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
DE102006003509A1 (de) *	2006-01-24	2007-07-26	Grünenthal GmbH	Kontrazeptivum
DE102006003508A1 (de) *	2006-01-24	2007-07-26	Grünenthal GmbH	Arzneimittel umfassend eine Hormonkombination

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GR79447B (no) *	1982-12-31	1984-10-30	Mortimer Christopher H Dr
DE3442857A1 (de) *	1984-11-22	1986-05-22	Schering AG, 1000 Berlin und 4709 Bergkamen	Mittel zur behandlung von androgenisierungserscheinungen bei der frau
DE3916112A1 (de) *	1989-05-16	1990-11-22	Schering Ag	Dihydrospirorenon als antiandrogen
DE4104385C1 (no) *	1991-02-09	1992-08-13	Marika Dr.Med. 6509 Framersheim De Ehrlich

1993
- 1993-07-01 DE DE4321957A patent/DE4321957C2/de not_active Expired - Lifetime
1994
- 1994-06-03 ES ES94916880T patent/ES2164103T3/es not_active Expired - Lifetime
- 1994-06-03 AT AT94916880T patent/ATE205716T1/de not_active IP Right Cessation
- 1994-06-03 DK DK94916880T patent/DK0710111T3/da active
- 1994-06-03 PT PT94916880T patent/PT710111E/pt unknown
- 1994-06-03 CA CA002166121A patent/CA2166121A1/en not_active Abandoned
- 1994-06-03 DE DE59409869T patent/DE59409869D1/de not_active Expired - Fee Related
- 1994-06-03 UA UA95125308A patent/UA43337C2/uk unknown
- 1994-06-03 WO PCT/DE1994/000629 patent/WO1995001180A1/de not_active Ceased
- 1994-06-03 HU HU9503770A patent/HUT73234A/hu unknown
- 1994-06-03 BR BR9407340A patent/BR9407340A/pt not_active Application Discontinuation
- 1994-06-03 AU AU68408/94A patent/AU695894B2/en not_active Ceased
- 1994-06-03 JP JP7503202A patent/JPH09500112A/ja active Pending
- 1994-06-03 EP EP94916880A patent/EP0710111B1/de not_active Expired - Lifetime
1995
- 1995-12-29 NO NO955347A patent/NO308586B1/no unknown

Also Published As

Publication number	Publication date
AU695894B2 (en)	1998-08-27
CA2166121A1 (en)	1995-01-12
BR9407340A (pt)	1996-10-08
WO1995001180A1 (de)	1995-01-12
DE4321957A1 (de)	1995-01-12
NO955347D0 (no)	1995-12-29
ES2164103T3 (es)	2002-02-16
AU6840894A (en)	1995-01-24
NO308586B1 (no)	2000-10-02
HU9503770D0 (en)	1996-02-28
DK0710111T3 (da)	2001-12-10
JPH09500112A (ja)	1997-01-07
EP0710111B1 (de)	2001-09-19
EP0710111A1 (de)	1996-05-08
UA43337C2 (uk)	2001-12-17
PT710111E (pt)	2002-02-28
DE59409869D1 (de)	2001-10-25
HUT73234A (en)	1996-07-29
DE4321957C2 (de)	1995-09-28
ATE205716T1 (de)	2001-10-15

Similar Documents

Publication	Publication Date	Title
BR9408513A (pt)	1997-08-19	Agente e método para a contracepçÃo hormonal e/ou para o tratamento de acne
ES2140658T3 (es)	2000-03-01	Sistemas terapeuticos transdermicos que contienen esteroides sexuales.
TW429152B (en)	2001-04-11	A tretinoin aqueous gel composition for therapeutic topical administration to the skin
ATE296612T1 (de)	2005-06-15	Wirkstoffe für die behandlung der senilen xerosis und zubereitungen
DE69432752D1 (de)	2003-07-03	Zusammensetzung zur substitutionstherapie, die mindestens ein progestogen und mindestens ein oestrogen enthält
AU1255002A (en)	2002-05-21	Delayed-release pharmaceutical formulations
ES2178048T3 (es)	2002-12-16	Uso de rifaximina como medicamento para el tratamiento de diarrea por criptosporidiosis.
DE68912195D1 (de)	1994-02-24	Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
ATE152628T1 (de)	1997-05-15	Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
DK0714304T3 (da)	2000-10-16	Terapeutisk system til behandling af psoriasis
NO955347D0 (no)	1995-12-29	Hormonelt middel for terapi av akne samt anvendelse derav
ATE237331T1 (de)	2003-05-15	Deuterierte wirkstoffe in transdermaler applikation
AU1604592A (en)	1992-12-03	New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
YU56702A (sh)	2005-09-19	Korišćenje fsh za lečenje neplodnosti
MX9709684A (es)	1998-06-28	Uso de derivados de vitamina d4 para tratamiento de trastornos de la piel.
UA19504A (uk)	1997-12-25	Засіб для лікуваhhя гhійhих запалеhь шкіри та підшкірhої клітковиhи
KR970005296A (ko)	1997-02-19	편도선염 치료제
MX9605916A (es)	1998-05-31	Compuestos bioaromaticos que llevan un grupo adamantilo en para, composiciones farmaceuticos y cosmeticas que los contienen y utilizaciones.
RU95100512A (ru)	1997-11-10	Мазь для лечения кожных заболеваний
MX9800697A (es)	1998-09-30	Uso de glicosidos de calendula para el tratamiento de psoriasis.
GR1003059B (el)	1999-01-27	Βαλσαμινοελαιολαδο προιον αναγεννησης μαλλιων
UA79424C2 (en)	2007-06-25	Use of fsh for treatment of infertility in women